Faculty Advisor

 Silvio E. Inzucchi, MD  

 Silvio E. Inzucchi, MD  Professor of Medicine
Professor of Medicine
  Division of Endocrinology
Clinical Director,
  Section of Endocrinology
Director, Endocrinology
  and Metabolism Fellowship
Director, Yale Diabetes Center
Yale University School of Medicine
New Haven, Connecticut

Dr Inzucchi is a Professor of Medicine in the Division of Endocrinology, Clinical Director of the Section of Endocrinology, Director of the Endocrinology and Metabolism Fellowship, and Director of the Yale Diabetes Center at Yale University School of Medicine in New Haven, Connecticut.

An invited lecturer both nationally and internationally on a variety of topics, including diabetes, lipid disorders, and pituitary disease, Dr Inzucchi has authored or co-authored more than 100 manuscripts, textbook chapters, and abstracts, with some of these published in the foremost medical journals, including The New England Journal of Medicine and Journal of the American Medical Association. His practical booklet on diabetes management, The Yale Diabetes Center Diabetes Facts & Guidelines, has an annual circulation in excess of 100,000 copies. Dr Inzucchi's research interests include the connection between type 2 diabetes, insulin resistance, and cardiovascular complications; the evaluation of the asymptomatic diabetic patient for coronary artery disease; and the inpatient management of hyperglycemia.

Dr Inzucchi received his undergraduate degree from Fordham University in the Bronx, New York, and his medical degree from Harvard Medical School in Boston, Massachusetts. He completed his internship and residency in Internal Medicine and his post-doctoral fellowship in Endocrinology and Metabolism at Yale-New Haven Hospital, in New Haven, Connecticut.

Dr Inzucchi has reported the following financial disclosures: retained consultant for Merck & Co., Inc., Boehringer Ingelheim, and Novo Nordisk; grant/research support from Takeda; steering committee member and consultant for Takeda; DMC member for Novo Nordisk; lecturer to company staff for AstraZeneca; study drug/placebo only for clinical trial from Takeda.

Last updated June 2015

BG Footer